The Journal of Immunology
However, the concentrations of both allopurinol and oxypurinol achieved during in vivo pharmacotherapy seem to be too low for their antioxidant effect (if there is any) to be of therapeutic importance (Halliwell and Gutteridge, 2015)
Joint mobility increases, inflammation decreases noticeably, and tissue quality improves as measured by reduced swelling and improved palpation findings
Its value is most evident in obese individuals or those who regularly exercise
Existing observational studies comparing weight reduction with these two treatments were conducted in patients with and without type 2 diabetes before FDA approval of tirzepatide for obesity management [8,9,10,11,12,13,14,15]